Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-6-22
pubmed:abstractText
Immunodominance limits the TCR diversity of specific antiviral CD8 T cell responses elicited by vaccination or infection. To prime multispecific T cell responses, we constructed DNA vaccines that coexpress chimeric, multidomain Ags (with CD8 T cell-defined epitopes of the hepatitis B virus (HBV) surface (S), core (C), and polymerase (Pol) proteins and/or the OVA Ag as stress protein-capturing fusion proteins. Priming of mono- or multispecific, HLA-A*0201- or K(b)-restricted CD8 T cell responses by these DNA vaccines differed. K(b)/OVA(257-264)- and K(b)/S(190-197)-specific CD8 T cell responses did not allow priming of a K(b)/C(93-100)-specific CD8 T cell response in mice immunized with multidomain vaccines. Tolerance to the S- Ag in transgenic Alb/HBs mice (that express large amounts of transgene-encoded S- Ag in the liver) facilitated priming of subdominant, K(b)/C(93-100)-specific CD8 T cell immunity by multidomain Ags. The "weak" (i.e., easily suppressed) K(b)/C(93-100)-specific CD8 T cell response was efficiently elicited by a HBV core Ag-encoding vector in 1.4HBV-S(mut) tg mice (that harbor a replicating HBV genome that produces HBV surface, core, and precore Ag in the liver). K(b)/C(93-100)-specific CD8 T cells accumulated in the liver of vaccinated 1.4HBV-S(mut) transgenic mice where they suppressed HBV replication. Subdominant epitopes in vaccines can hence prime specific CD8 T cell immunity in a tolerogenic milieu that delivers specific antiviral effects to HBV-expressing hepatocytes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1550-6606
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
183
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
370-80
pubmed:meshHeading
pubmed-meshheading:19542448-Animals, pubmed-meshheading:19542448-Antigens, Polyomavirus Transforming, pubmed-meshheading:19542448-CD8-Positive T-Lymphocytes, pubmed-meshheading:19542448-Cell Line, pubmed-meshheading:19542448-Epitopes, T-Lymphocyte, pubmed-meshheading:19542448-Female, pubmed-meshheading:19542448-H-2 Antigens, pubmed-meshheading:19542448-HSP70 Heat-Shock Proteins, pubmed-meshheading:19542448-Hepatitis B Core Antigens, pubmed-meshheading:19542448-Hepatitis B Vaccines, pubmed-meshheading:19542448-Hepatitis B e Antigens, pubmed-meshheading:19542448-Hepatitis B virus, pubmed-meshheading:19542448-Humans, pubmed-meshheading:19542448-Immunodominant Epitopes, pubmed-meshheading:19542448-Liver Diseases, pubmed-meshheading:19542448-Lymphocyte Activation, pubmed-meshheading:19542448-Male, pubmed-meshheading:19542448-Mice, pubmed-meshheading:19542448-Mice, Inbred C57BL, pubmed-meshheading:19542448-Mice, Transgenic, pubmed-meshheading:19542448-Protein Binding, pubmed-meshheading:19542448-Protein Structure, Tertiary, pubmed-meshheading:19542448-Vaccines, DNA, pubmed-meshheading:19542448-Virus Replication
pubmed:year
2009
pubmed:articleTitle
Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
pubmed:affiliation
Department of Internal Medicine I, University of Ulm, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't